NOVARTIS | BLUE PEARL TEXSPIN | NOVARTIS/ BLUE PEARL TEXSPIN |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 26.6 | 566.1 | 4.7% | View Chart |
P/BV | x | 3.3 | - | - | View Chart |
Dividend Yield | % | 4.6 | 0.0 | - |
NOVARTIS BLUE PEARL TEXSPIN |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
BLUE PEARL TEXSPIN Mar-23 |
NOVARTIS/ BLUE PEARL TEXSPIN |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 36 | 2,150.0% | |
Low | Rs | 554 | 25 | 2,176.8% | |
Sales per share (Unadj.) | Rs | 153.4 | 8.6 | 1,788.5% | |
Earnings per share (Unadj.) | Rs | 41.9 | -0.3 | -15,549.2% | |
Cash flow per share (Unadj.) | Rs | 44.3 | -0.3 | -16,460.8% | |
Dividends per share (Unadj.) | Rs | 47.50 | 0 | - | |
Avg Dividend yield | % | 7.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 314.2 | -4.5 | -7,041.9% | |
Shares outstanding (eoy) | m | 24.69 | 0.26 | 9,496.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 3.5 | 123.0% | |
Avg P/E ratio | x | 15.7 | -107.6 | -14.6% | |
P/CF ratio (eoy) | x | 14.9 | -107.6 | -13.8% | |
Price / Book Value ratio | x | 2.1 | -6.7 | -31.2% | |
Dividend payout | % | 113.5 | 0 | - | |
Avg Mkt Cap | Rs m | 16,262 | 8 | 208,420.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 0 | 178,200.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 2 | 169,838.6% | |
Other income | Rs m | 581 | 0 | - | |
Total revenues | Rs m | 4,369 | 2 | 195,896.9% | |
Gross profit | Rs m | 651 | 0 | -929,714.3% | |
Depreciation | Rs m | 61 | 0 | - | |
Interest | Rs m | 18 | 0 | - | |
Profit before tax | Rs m | 1,154 | 0 | -1,648,285.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 0 | - | |
Profit after tax | Rs m | 1,034 | 0 | -1,476,571.4% | |
Gross profit margin | % | 17.2 | -3.2 | -535.2% | |
Effective tax rate | % | 10.4 | 0 | - | |
Net profit margin | % | 27.3 | -3.2 | -847.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 2 | 457,011.6% | |
Current liabilities | Rs m | 2,683 | 3 | 86,257.2% | |
Net working cap to sales | % | 136.7 | -62.4 | -218.9% | |
Current ratio | x | 2.9 | 0.6 | 529.8% | |
Inventory Days | Days | 1,201 | 35 | 3,477.7% | |
Debtors Days | Days | 35 | 1,348,184 | 0.0% | |
Net fixed assets | Rs m | 12,656 | 0 | 5,502,565.2% | |
Share capital | Rs m | 123 | 3 | 4,820.3% | |
"Free" reserves | Rs m | 7,634 | -4 | -205,204.3% | |
Net worth | Rs m | 7,757 | -1 | -668,706.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,517 | 2 | 1,057,572.2% | |
Interest coverage | x | 66.9 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.2 | 1.1 | 16.1% | |
Return on assets | % | 5.1 | -3.7 | -138.8% | |
Return on equity | % | 13.3 | 6.2 | 215.3% | |
Return on capital | % | 15.1 | 6.2 | 244.6% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | 0 | -97,391.3% | |
From Investments | Rs m | -1,533 | NA | - | |
From Financial Activity | Rs m | -305 | 1 | -60,960.0% | |
Net Cashflow | Rs m | -1,389 | 0 | -3,473,250.0% |
Indian Promoters | % | 0.0 | 0.1 | - | |
Foreign collaborators | % | 70.7 | 19.5 | 361.7% | |
Indian inst/Mut Fund | % | 0.7 | 0.0 | 3,550.0% | |
FIIs | % | 0.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 80.3 | 36.5% | |
Shareholders | 43,128 | 8,415 | 512.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA SAT INDUSTRIES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | E-WHA FOAM (I) | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.22% | 0.00% | 1.18% |
1-Month | 7.46% | 4.98% | -0.75% |
1-Year | 81.59% | 25.40% | 61.82% |
3-Year CAGR | 23.12% | 59.11% | 18.16% |
5-Year CAGR | 8.47% | 27.07% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the E-WHA FOAM (I) share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of E-WHA FOAM (I) the stake stands at 19.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of E-WHA FOAM (I).
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
E-WHA FOAM (I) paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of E-WHA FOAM (I).
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.